Pharmaceutical company Pfizer will launch its antiretroviral drug maraviroc in July after FDA tests conclude in the U.S., Richard Paulson, head of Pfizer in South Africa, said on Wednesday, AFP/Japan Today reports. According to an unnamed Pfizer spokesperson, the drug, which will be taken orally, is scheduled to be formally approved by FDA on June 20. Source.
No comments:
Post a Comment